Marek Łoś
Impact in
- Epidemiology top 0.5%
- Autophagy in Disease and Therapy
- Molecular Biology top 0.5%
- Cell death mechanisms and regulation
- Natural product bioactivities and synthesis
- Redox biology and oxidative stress
Papers in
-
- Cell death mechanisms and regulation 69
- Pluripotent Stem Cells Research 7
- PI3K/AKT/mTOR signaling in cancer 6
- Oncology 22
- Cancer-related Molecular Pathways 10
- Cancer Cells and Metastasis 6
- Co-authors
- Klaus Schulze‐Osthoff (37 shared papers)Saeid Ghavami (79 shared papers)Sebastian Wesselborg (12 shared papers)Davide Ferrari (4 shared papers)Mohammad Mostakhdem Hashemi (18 shared papers)Sudharsana Rao Ande (10 shared papers)Emilia Wiecheć (11 shared papers)Patrick Alexander Baeuerle (5 shared papers)
In The Last Decade
Marek Łoś
196 papers receiving 20.3k citations
Marek Łoś's Hit Papers
Peers
Comparison fields: 5 of 155
- Epidemiology 3.8k
- Molecular Biology 7.4k
- Cancer Research 1.1k
- Genetics 701
- Physiology 306
Countries citing papers authored by Marek Łoś
This map shows the geographic impact of Marek Łoś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Łoś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Łoś more than expected).
Fields of papers citing papers by Marek Łoś
This network shows the impact of papers produced by Marek Łoś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Łoś. The network helps show where Marek Łoś may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Łoś, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Hit paper breakdown → | 2016 | 4680 |
| 2 | Autophagy and apoptosis dysfunction in neurodegenerative disorders Hit paper breakdown → | 2013 | 893 |
| 3 | Apoptosis signaling by death receptors Hit paper breakdown → | 1998 | 848 |
| 4 | 2009 | 594 | |
| 5 | 1995 | 570 | |
| 6 | 2002 | 439 | |
| 7 | 2007 | 394 | |
| 8 | 1999 | 352 | |
| 9 | 1995 | 348 | |
| 10 | 2008 | 344 | |
| 11 | Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. | 1997 | 319 |
| 12 | 1995 | 279 | |
| 13 | 1999 | 277 | |
| 14 | 2008 | 272 | |
| 15 | 1999 | 248 | |
| 16 | 2012 | 246 | |
| 17 | 1995 | 240 | |
| 18 | 2019 | 222 | |
| 19 | 2009 | 216 | |
| 20 | 2021 | 210 |
About Marek Łoś
Marek Łoś is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Cancer Research, having authored 204 papers that have together received 20.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (69 papers), Autophagy in Disease and Therapy (22 papers), Cancer-related Molecular Pathways (10 papers), Pluripotent Stem Cells Research (7 papers), Bone Tissue Engineering Materials (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Epidemiology (3.8k citations), Molecular Biology (7.4k citations), Cancer Research (1.1k citations), Genetics (701 citations) and Physiology (306 citations). Marek Łoś has collaborated with scholars based in Canada, Poland and Germany. Frequent co-authors include Klaus Schulze‐Osthoff, Saeid Ghavami, Sebastian Wesselborg, Davide Ferrari, Mohammad Mostakhdem Hashemi, Sudharsana Rao Ande, Emilia Wiecheć, Patrick Alexander Baeuerle, Subbareddy Maddika and Thomas C. Klonisch. Their work appears in journals such as European Journal of Pharmacology, International Journal of Molecular Sciences, Archivum Immunologiae et Therapiae Experimentalis, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Drug Resistance Updates.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.